In response to platinum drug treatments, prostate cancer cells exhibited highly heterologous changes in distribution of Coilin-immunopositivity in relation to nucleoli (Fig. 5) with frequent localization of Coilin close or within the nucleoli. The gene discussed is COIL; the disease is prostate cancer.